Clinical Trial Update: R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated R115777 (tipifarnib) in patients with metastatic pancreatic cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• R115777 (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED